Literature DB >> 33468684

Sterilization by Adaptive Immunity of a Conditionally Persistent Mutant of Mycobacterium tuberculosis.

Catherine Vilchèze1, Steven A Porcelli1, John Chan1, William R Jacobs2.   

Abstract

Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, can enter into a persistent state that confers resistance to antibacterial agents. Many observations suggest that persistent M. tuberculosis cells also evade the antimycobacterial immune mechanisms, thereby reducing the effectiveness of the current tuberculosis vaccine. Understanding the factors that contribute to persistence may enable the rational design of vaccines that stimulate effective immune killing mechanisms against persister cells. Independent mutations targeting the methionine and arginine biosynthetic pathways are bactericidal for M. tuberculosis in mice. However, in this study, we discovered that the addition of leucine and pantothenate auxotrophy altered the bactericidality of methionine auxotrophy. Whereas the leucine/pantothenate/methionine auxotrophic M. tuberculosis strain H37Rv ΔleuCD ΔpanCD ΔmetA was eliminated in immunocompetent mice, this strain persisted in multiple organs of immunodeficient Rag1-/- mice for at least a year. In contrast, the leucine/pantothenate/arginine auxotroph H37Rv ΔleuCD ΔpanCD ΔargB was eliminated in both immunocompetent and immunodeficient Rag1-/- mice. Our results showed that leucine and pantothenate starvation metabolically blocked the sterilization mechanisms of methionine starvation but not those of arginine starvation. These triple-auxotrophic strains should be invaluable tools for unravelling the bacterial and host factors that enable persistence and for vaccine development studies to assess the efficacy of vaccines that boost immune recognition of M. tuberculosis in the persistent state. The sterilization of the ΔleuCD ΔpanCD ΔmetA auxotroph in immunocompetent mice, but not in mice lacking an adaptive immune response, could provide a new system for studying the antimycobacterial killing mechanisms of adaptive immunity.IMPORTANCE The bacterial pathogen Mycobacterium tuberculosis can enter into a persistent state in which M. tuberculosis can evade host immunity, thereby reducing the effectiveness of current tuberculosis vaccines. Understanding the factors that contribute to persistence would enable the rational design of vaccines effective against persisters. We previously generated two attenuated, triple-auxotrophic M. tuberculosis strains that are safe to use in a biosafety level 2 laboratory. Herein, we discovered that the triple-auxotrophic strain H37Rv ΔleuCD ΔpanCD ΔmetA persisted in immunodeficient Rag1-/- mice, which lack adaptive immunity, but not in immunocompetent mice. The conditional persistence of this auxotrophic mutant, which is susceptible to the sterilizing effect of the adaptive immune response over time, provides an important tool to dissect the mycobactericidal effector mechanisms mediated by adaptive immunity. Furthermore, because of its remarkable safety attributes, this auxotrophic mutant can potentially be used to develop a practical human challenge model to facilitate vaccine development.
Copyright © 2021 Vilchèze et al.

Entities:  

Keywords:  Mycobacterium tuberculosis; conditional persistence; sterilizing immunity

Year:  2021        PMID: 33468684      PMCID: PMC7845640          DOI: 10.1128/mBio.02391-20

Source DB:  PubMed          Journal:  mBio            Impact factor:   7.867


  23 in total

1.  Bacillus Calmette-Guérin in Immunosuppressed Patient with High-Grade Nonmuscle Invasive Bladder Carcinoma.

Authors:  Laura Aznar Martínez; Pedro López Cubillana; Alicia López Abad; Natalia Vidal Crespo; Guillermo Antonio Gómez Gómez
Journal:  Urol Int       Date:  2019-07-03       Impact factor: 2.089

2.  Pilot studies of a human BCG challenge model.

Authors:  Azra Blazevic; Mei Xia; Aldin Turan; Janice Tennant; Daniel F Hoft
Journal:  Tuberculosis (Edinb)       Date:  2017-05-04       Impact factor: 3.131

3.  Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti.

Authors:  Alexander S Pym; Priscille Brodin; Roland Brosch; Michel Huerre; Stewart T Cole
Journal:  Mol Microbiol       Date:  2002-11       Impact factor: 3.501

Review 4.  Exacting Edward Jenner's revenge: The quest for a new tuberculosis vaccine.

Authors:  Steven A Porcelli; William R Jacobs
Journal:  Sci Transl Med       Date:  2019-05-01       Impact factor: 17.956

5.  Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection.

Authors:  Matthias I Gröschel; Fadel Sayes; Sung Jae Shin; Wafa Frigui; Alexandre Pawlik; Mickael Orgeur; Robin Canetti; Nadine Honoré; Roxane Simeone; Tjip S van der Werf; Wilbert Bitter; Sang-Nae Cho; Laleh Majlessi; Roland Brosch
Journal:  Cell Rep       Date:  2017-03-14       Impact factor: 9.423

6.  Arginine-deprivation-induced oxidative damage sterilizes Mycobacterium tuberculosis.

Authors:  Sangeeta Tiwari; Andries J van Tonder; Catherine Vilchèze; Vitor Mendes; Sherine E Thomas; Adel Malek; Bing Chen; Mei Chen; John Kim; Tom L Blundell; Julian Parkhill; Brian Weinrick; Michael Berney; William R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-24       Impact factor: 11.205

7.  The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue.

Authors:  Tsungda Hsu; Suzanne M Hingley-Wilson; Bing Chen; Mei Chen; Annie Z Dai; Paul M Morin; Carolyn B Marks; Jeevan Padiyar; Celia Goulding; Mari Gingery; David Eisenberg; Robert G Russell; Steven C Derrick; Frank M Collins; Sheldon L Morris; C Harold King; William R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-13       Impact factor: 11.205

8.  Dual-Reporter Mycobacteriophages (Φ2DRMs) Reveal Preexisting Mycobacterium tuberculosis Persistent Cells in Human Sputum.

Authors:  Paras Jain; Brian C Weinrick; Eric J Kalivoda; Hui Yang; Vanisha Munsamy; Catherine Vilcheze; Torin R Weisbrod; Michelle H Larsen; Max R O'Donnell; Alexander Pym; William R Jacobs
Journal:  mBio       Date:  2016-10-25       Impact factor: 7.867

9.  Five colour variants of bright luminescent protein for real-time multicolour bioimaging.

Authors:  Kazushi Suzuki; Taichi Kimura; Hajime Shinoda; Guirong Bai; Matthew J Daniels; Yoshiyuki Arai; Masahiro Nakano; Takeharu Nagai
Journal:  Nat Commun       Date:  2016-12-14       Impact factor: 14.919

10.  Red-shifted luciferase-luciferin pairs for enhanced bioluminescence imaging.

Authors:  Hsien-Wei Yeh; Omran Karmach; Ao Ji; David Carter; Manuela M Martins-Green; Hui-Wang Ai
Journal:  Nat Methods       Date:  2017-09-04       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.